CTIS.eu › Cities › France › Montpellier Cedex 5
Montpellier Cedex 5
France
846 total trials
379 recruiting
2024-513444-28-00
5
Acute ischaemic stroke due to basilar artery occlusion.
2024-513724-42-00
10
Medulloblastoma
2024-513889-19-00
5
Multiple Myeloma
2024-514633-38-00
5
Crohn’s Disease
2024-514659-13-00
5
Patients with severe forms of Recurrent Aphthous Stomatitis (RAS)
2024-514848-88-00
4
Folliculitis decalvans
2024-514964-24-00
5
ulcerative colitis
2024-515339-30-00
4
Ovarian Cancer
2024-515340-23-00
4
Colon cancer
2024-515362-13-00
10
Philadelphia-negative myeloproliferative neoplasms are frequent and ch
2024-515663-59-00
5
intracerebral haemorrhage
2024-515834-34-00
5
complicated acute appendicitis
2024-516167-86-00
5
Patients referred for an isolated or a combined surgical correction of
2024-516570-30-00
4
Relapsed/refractory T-cell Acute Lymphoblastic Leukemia
2024-516849-39-01
5
antibiotic therapy in Sepsis
2024-516918-37-00
4
Diffuse low-grade gliomas
2024-518219-20-00
6
Transient hypercalciuria
2024-518516-39-00
4
Systemic sclEroderma
2024-519003-99-00
4
Hidrdenitis suppurative
2024-519166-48-01
4
Posterior Urethral Valves
2024-519402-12-00
5
uncomplicated appendicitis
2024-519753-11-00
4
Resectable borderline pancreatic adenocarcinoma
2024-519986-23-00
5
The study will involve adult women and men from 16 French centers who
2024-520089-70-00
5
Cutaneous lupus erythematosus
Showing 25–48 of 846 trials